Ac-cording to Hwang et al. [20], an ER (+)/PR (+)/CD10 (+)/GEM (−)/h-caldesmon (−)/transgelin (−) im-munoprofile reliably distinguishes LG-ESS from uterine leiomyosarcoma [18,19,20,45,46,47]. Here, CALD1 is linked to leiomyosarcoma.